# A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects

> **NCT02572245** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 164 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DEVICE:** PF-06410293 PFS
- **DEVICE:** PF-06410293 PFP

## Key facts

- **NCT ID:** NCT02572245
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2016-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02572245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02572245, "A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02572245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*